Recap: Rollins Q2 Earnings

  Rollins (NYSE:ROL) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Rollins reported in-line EPS of $0.2 versus an estimate of $0.2.

 

Rollins (NYSE:ROL) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Rollins reported in-line EPS of $0.2 versus an estimate of $0.2.

Revenue was up $75.84 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 2.75% increase in the share price the next day.

Here’s a look at Rollins’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.14 0.15 0.20 0.18
EPS Actual 0.15 0.14 0.19 0.20
Revenue Estimate 575.93M 585.03M 645.84M 613.94M
Revenue Actual 590.68M 600.34M 650.20M 638.20M

To track all earnings releases for Rollins visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System

Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System. Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.

CFMS